PRKN and lung carcinoma: Mitophagy appears to be tumor-promoting or tumor-suppressive, depending on the tumor type and intrinsic stage (30). For instance, PARK2, which encodes a core mitophagy protein, Parkin, was found to be inactivated in colon and lung cancer (31).